IL-33/ST2 pathway contributes to metastasis of human colorectal cancer

Biochemical and Biophysical Research Communications

Volumn 453, Issue 3, 2014, Pages 486-492

  Liu, Xuejian ^a   Zhu, Leilei ^b   Lu, Xin ^b   Bian, Hairong ^b   Wu, Xia ^a   Yang, Wenchuan ^a   Qin, Qingliang ^b  

^a Department of Oncology People's Hospital of Linyi Economic and Technological Development Zone   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Colorectal cancer; IL 33; ST2; Tumor metastasis

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GELATINASE A; GELATINASE B; INTERLEUKIN 33; INTERLEUKIN 6; CELL SURFACE RECEPTOR; CXCR4 PROTEIN, HUMAN; IL1RL1 PROTEIN, HUMAN; IL33 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL GROWTH; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MOUSE; NONHUMAN; STIMULATION; SURVIVAL TIME; COLORECTAL TUMOR; FLOW CYTOMETRY; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

MUS MUSCULUS;

COLORECTAL NEOPLASMS; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-6; INTERLEUKINS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM METASTASIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE; RECEPTORS, CXCR4;

EID: 84918555747     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.09.106     Document Type: Article

References (30)

1. M. Mathonnet, A. Perraud, N. Christou, et al., Hallmarks in colorectal cancer: angiogenesis and cancer stem-like cells, World J. Gastroenterol. 20 (2014) 4189-4196.
2. A.S. Walker, E.K. Johnson, J.A. Maykel, et al., Future directions for the early detection of colorectal cancer recurrence, J. Cancer 5 (2014) 272-280.
3. H. Zhao, Z. Xu, H. Qin, et al., MiR-30b regulates migration and invasion of human colorectal cancer via SIX1, Biochem. J. 460 (2014) 117-125.
4. S. Rasool, S.A. Kadla, V. Rasool, et al., A comparative overview of general risk factors associated with the incidence of colorectal cancer, Tumour Biol. 34 (2013) 2469-2476.
5. M. Milovanovic, V. Volarevic, G. Radosavljevic, et al., IL-33/ST2 axis in inflammation and immunopathology, Immunol. Res. 52 (2012) 89-99.
6. M. Gadina, C.A. Jefferies, IL-33: a sheep in wolf's clothing?, Sci STKE 2007 (2007) pe31.
7. I.P. Jovanovic, N.N. Pejnovic, G.D. Radosavljevic, et al., Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells, Int. J. Cancer 134 (2014) 1669-1682.
8. L.A. Hu, Y. Fu, D.N. Zhang, et al., Serum IL-33 as a diagnostic and prognostic marker in non-small cell lung cancer, Asian Pac. J. Cancer Prev. 14 (2013) 2563-2566.
9. D. Bergis, V. Kassis, A. Ranglack, et al., High serum levels of the interleukin-33 receptor soluble ST2 as a negative prognostic factor in hepatocellular carcinoma, Transl. Oncol. 6 (2013) 311-318.
10. R. Guabiraba, A.G. Besnard, G.B. Menezes, et al., IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice, Mucosal Immunol. 7 (2014) 1079-1093.
11. Z. Wen, L. Xu, X. Chen, et al., Autoantibody induction by DNA-containing immune complexes requires HMGB1 with the TLR2/microRNA-155 pathway, J. Immunol. 190 (2013) 5411-5422.
12. Z. Huang, S. Huang, Q. Wang, et al., MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma, Cancer Res. 71 (2011) 2582-2589.
13. Q. Li, Y. Han, G. Fei, et al., IL-17 promoted metastasis of non-small-cell lung cancer cells, Immunol. Lett. 148 (2012) 144-150.
14. D.F. Quail, J.A. Joyce, Microenvironmental regulation of tumor progression and metastasis, Nat. Med. 19 (2013) 1423-1437.
15. S. Valastyan, R.A. Weinberg, Tumor metastasis: molecular insights and evolving paradigms, Cell 147 (2011) 275-292.
16. L.R. Lopetuso, S. Chowdhry, T.T. Pizarro, Opposing functions of classic and novel IL-1 family members in gut health and disease, Front. Immunol. 4 (2013) 181.
17. J. Liu, J.X. Shen, J.L. Hu, et al., Significance of interleukin-33 and its related cytokines in patients with breast cancers, Front. Immunol. 5 (2014) 141.
18. S.F. Chen, S. Nieh, S.W. Jao, et al., The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma, J. Pathol. 231 (2013) 180-189.
19. P. Zhang, X.K. Liu, Z. Chu, et al., Detection of interleukin-33 in serum and carcinoma tissue from patients with hepatocellular carcinoma and its clinical implications, J. Int. Med. Res. 40 (2012) 1654-1661.
20. A. Schmieder, G. Multhoff, J. Radons, Interleukin-33 acts as a pro-inflammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma cells, Cytokine 60 (2012) 514-521.
21. P. Sun, Q. Ben, S. Tu, et al., Serum interleukin-33 levels in patients with gastric cancer, Dig. Dis. Sci. 56 (2011) 3596-3601.
22. M. Rokavec, M.G. Öner, H. Li, et al., IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis, J. Clin. Invest. 124 (2014) 1853-1867.
23. T. Murakami, K. Kawada, M. Iwamoto, et al., The role of CXCR3 and CXCR4 in colorectal cancer metastasis, Int. J. Cancer 132 (2013) 276-287.
24. T. Hu, Y. Yao, S. Yu, et al., Clinicopathologic significance of CXCR4 and Nrf2 in colorectal cancer, J. Biomed. Res. 27 (2013) 283-290.
25. B. Wang, W. Wang, W. Niu, et al., SDF-1/CXCR4 axis promotes directional migration of colorectal cancer cells through upregulation of integrin αvβ6, Carcinogenesis 35 (2014) 282-291.
26. S. Yamada, M. Shimada, T. Utsunomiya, et al., CXC receptor 4 and stromal cell-derived factor 1 in primary tumors and liver metastases of colorectal cancer, J. Surg. Res. 187 (2014) 107-112.
27. T.B. Wang, B.G. Hu, D.W. Liu, et al., The influence of lentivirus-mediated CXCR4 RNA interference on hepatic metastasis of colorectal cancer, Int. J. Oncol. 44 (2014) 1861-1869.
28. Y. Dai, G. Wilson, B. Huang, et al., Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer, Cell Death Dis. 5 (2014) e1170.
29. M.A. Lee, J.H. Park, S.Y. Rhyu, et al., Wnt3a expression is associated with MMP-9 expression in primary tumor and metastatic site in recurrent or stage IV colorectal cancer, BMC Cancer 14 (2014) 125.
30. E. Kostova, M. Slaninka-Miceska, N. Labacevski, et al., Expression of matrix metalloproteinases 2, 7 and 9 in patients with colorectal cancer, Vojnosanit. Pregl. 71 (2014) 52-59.